This paper discusses some insights that an understanding of national cultural differences might provide into problems relating to the measurement of corporate success and the disclosure of success-related information in an increasingly international business context. Arguments and evidence are...

The IASC has suggested a number of ways by which listed companies could present financial statements that conform with International Accounting Standards (IAS). This paper considers the feasibility and usefulness of those options. In particular, the reconciliation of domestic financial...

The European Commission has long been concerned over the extensive disclosures required by the Securities and Exchange Commission (SEC) in form 20-F. As the IASC moves towards completing its core standards programme to the satisfaction of IOSCO, the debate has centred around the likelihood of...

The disclosure behaviour for a sample of quoted Swedish and UK pharmaceutical companies is investigated in the paper. The sample consists of three Swedish (Astra, Gambro and Pharmacia) and three UK (Glaxo, SmithKline Beecham and Wellcome) pharmaceutical companies, whose annual financial reports...

In order to enhance our understanding of the content and context of voluntary disclosures, the disclosure behaviour of a sample of Swedish and UK pharmaceutical companies is investigated in this paper. The investigation has been guided by a fundamental ("residual income") valuation model, based...